Literature DB >> 23673860

New MLLT10 gene recombinations in pediatric T-acute lymphoblastic leukemia.

Lucia Brandimarte1, Valentina Pierini, Danika Di Giacomo, Chiara Borga, Filomena Nozza, Paolo Gorello, Marco Giordan, Giovanni Cazzaniga, Geertruy Te Kronnie, Roberta La Starza, Cristina Mecucci.   

Abstract

The MLLT10 gene, located at 10p13, is a known partner of MLL and PICALM in specific leukemic fusions generated from recurrent 11q23 and 11q14 chromosome translocations. Deep sequencing recently identified NAP1L1/12q21 as another MLLT10 partner in T-cell acute lymphoblastic leukemia (T-ALL). In pediatric T-ALL, we have identified 2 RNA processing genes, that is, HNRNPH1/5q35 and DDX3X/Xp11.3 as new MLLT10 fusion partners. Gene expression profile signatures of the HNRNPH1- and DDX3X-MLLT10 fusions placed them in the HOXA subgroup. Remarkably, they were highly similar only to PICALM-MLLT10-positive cases. The present study showed MLLT10 promiscuity in pediatric T-ALL and identified a specific MLLT10 signature within the HOXA subgroup.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23673860     DOI: 10.1182/blood-2013-02-487256

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  27 in total

1.  Cryptic XPO1-MLLT10 translocation is associated with HOXA locus deregulation in T-ALL.

Authors:  Jonathan Bond; Aurélie Bergon; Amandine Durand; Isabelle Tigaud; Xavier Thomas; Vahid Asnafi; Salvatore Spicuglia; Elizabeth Macintyre
Journal:  Blood       Date:  2014-11-06       Impact factor: 22.113

2.  Genomic Profiling of a Large Set of Diverse Pediatric Cancers Identifies Known and Novel Mutations across Tumor Spectra.

Authors:  Juliann Chmielecki; Mark Bailey; Jie He; Julia Elvin; Jo-Anne Vergilio; Shakti Ramkissoon; James Suh; Garrett M Frampton; James X Sun; Samantha Morley; Daniel Spritz; Siraj Ali; Laurie Gay; Rachel L Erlich; Jeffrey S Ross; Joana Buxhaku; Hilary Davies; Vinny Faso; Alexis Germain; Blair Glanville; Vincent A Miller; Philip J Stephens; Katherine A Janeway; John M Maris; Soheil Meshinchi; Trevor J Pugh; Jack F Shern; Doron Lipson
Journal:  Cancer Res       Date:  2017-01-09       Impact factor: 12.701

3.  DDX3X-MLLT10 fusion in adults with NOTCH1 positive T-cell acute lymphoblastic leukemia.

Authors:  Lucia Brandimarte; Roberta La Starza; Valentina Gianfelici; Gianluca Barba; Valentina Pierini; Danika Di Giacomo; Jan Cools; Loredana Elia; Antonella Vitale; Luigiana Luciano; Antonella Bardi; Sabina Chiaretti; Caterina Matteucci; Giorgina Specchia; Cristina Mecucci
Journal:  Haematologica       Date:  2014-02-28       Impact factor: 9.941

4.  HOXA-activated early T-cell progenitor acute lymphoblastic leukemia: predictor of poor outcome?

Authors:  Jules Pp Meijerink; Kirsten Canté-Barrett; Eric Vroegindeweij; Rob Pieters
Journal:  Haematologica       Date:  2016-06       Impact factor: 9.941

5.  PPARγ targeted oral cancer treatment and additional utility of genomics analytic techniques.

Authors:  Nathan Handley; Jacob Eide; Randall Taylor; Beverly Wuertz; Patrick Gaffney; Frank Ondrey
Journal:  Laryngoscope       Date:  2016-11-29       Impact factor: 3.325

Review 6.  The DEAD-box protein family of RNA helicases: sentinels for a myriad of cellular functions with emerging roles in tumorigenesis.

Authors:  Mohamed A M Ali
Journal:  Int J Clin Oncol       Date:  2021-03-03       Impact factor: 3.402

7.  AF10 regulates progressive H3K79 methylation and HOX gene expression in diverse AML subtypes.

Authors:  Aniruddha J Deshpande; Anagha Deshpande; Amit U Sinha; Liying Chen; Jenny Chang; Ali Cihan; Maurizio Fazio; Chun-Wei Chen; Nan Zhu; Richard Koche; Liuda Dzhekieva; Gloria Ibáñez; Stuart Dias; Deepti Banka; Andrei Krivtsov; Minkui Luo; Robert G Roeder; James E Bradner; Kathrin M Bernt; Scott A Armstrong
Journal:  Cancer Cell       Date:  2014-11-20       Impact factor: 31.743

8.  Large-scale circular RNA deregulation in T-ALL: unlocking unique ectopic expression of molecular subtypes.

Authors:  Alessia Buratin; Maddalena Paganin; Enrico Gaffo; Anna Dal Molin; Juliette Roels; Giuseppe Germano; Maria Teresa Siddi; Valentina Serafin; Matthias De Decker; Stéphanie Gachet; Kaat Durinck; Frank Speleman; Tom Taghon; Geertruij Te Kronnie; Pieter Van Vlierberghe; Stefania Bortoluzzi
Journal:  Blood Adv       Date:  2020-12-08

9.  An early thymic precursor phenotype predicts outcome exclusively in HOXA-overexpressing adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.

Authors:  Jonathan Bond; Tony Marchand; Aurore Touzart; Agata Cieslak; Amélie Trinquand; Laurent Sutton; Isabelle Radford-Weiss; Ludovic Lhermitte; Salvatore Spicuglia; Hervé Dombret; Elizabeth Macintyre; Norbert Ifrah; Jean-François Hamel; Vahid Asnafi
Journal:  Haematologica       Date:  2016-03-04       Impact factor: 9.941

10.  Oncogenic ZEB2 activation drives sensitivity toward KDM1A inhibition in T-cell acute lymphoblastic leukemia.

Authors:  Steven Goossens; Sofie Peirs; Wouter Van Loocke; Jueqiong Wang; Mina Takawy; Filip Matthijssens; Stefan E Sonderegger; Katharina Haigh; Thao Nguyen; Niels Vandamme; Magdaline Costa; Catherine Carmichael; Filip Van Nieuwerburgh; Dieter Deforce; Oded Kleifeld; David J Curtis; Geert Berx; Pieter Van Vlierberghe; Jody J Haigh
Journal:  Blood       Date:  2017-01-09       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.